The FDA caused a stir last week when it approved a new, generic version of mifepristone—the abortion medication that has safely, effectively and privately ended pregnancies for 25 years. Many mainstream outlets made it sound like a dramatic policy reversal, but really it was a procedural box check. Meanwhile, the Trump administration is already laying the groundwork to undermine access, announcing a so-called “safety review” based on flawed data and false claims. As reproductive rights ...
